Biomarkers, CDx & precision medicine 2026

OHMX.bio will be attending Biomarkers, CDx & Precision Medicine Europe 2026, taking place on 13–14 October in Basel, Switzerland. You can find us at booth 52.
Now in its twenty-first year, this leading Oxford Global conference brings together the full precision medicine decision chain, from biomarker discovery and companion diagnostic development to clinical validation and patient stratification. It is exactly the kind of environment where we connect with researchers and clinical development teams looking for specialist multi-omics support.

At OHMX.bio, we support biomarker programmes from early discovery through to clinical validation, with services spanning RNA sequencing, ribosome profiling, proteomics, epigenomics, and single-cell analysis, all from an ISO-certified, Ghent University spin-off CRO.

Stop by booth 52 or get in touch ahead of the event to schedule a meeting with our team.

Search all posts

Popular news & events

Tags